African Stock Exchanges

DASPHARMA - Dannex Ayrton Starwin Plc

Twitter · Facebook
DASPHARMA share price on Ghana Stock ExchangeDASPHARMA share price on Ghana Stock Exchange

Dannex Ayrton Starwin Plc is the largest pharmaceutical manufacturing company in Ghana. Located in the hub of industrial activity, the company is recognized as a pioneer in the manufacturing of high quality pharmaceutical drugs with a distribution network throughout West Africa. It was initially founded in May 1964 as Dannex Limited, a wholly owned private limited liability company, for the express purpose of manufacturing and distribution of pharmaceutical products. However, in 2014 and 2016 respectively, Dannex acquired majority shares in industry giants Starwin Products Limited (71.33%) and Ayrton Drug Manufacturing Limited (53.47%). All three companies were subsequently merged in 2019 to create Dannex Ayrton Starwin Plc.

Dannex Ayrton Starwin has a product range that includes tablets, capsules, liquids (syrups and suspensions), powders, ointments, chemicals (disinfectants) and veterinary products. With a strong distribution network, the company has wholesalers, retailers, and distribution points in all regions of Ghana. Additionally, they supply to other countries within the West African region.

Dannex Ayrton Starwin Plc is listed on the Ghana Stock Exchange (GSE) since January 15th, 2020. Dannex Ayrton Starwin is traded on the GSE under the ticker symbol “DASPHARMA”. The International Securities Identification Number (ISIN) of GSE:DASPHARMA is GHEDASP58306. Dannex Ayrton Starwin Plc is currently the 27th most valuable stock on the GSE with a market capitalization of GHS 33.9 million, which is about 0.046% of the Ghana Stock Exchange equity market.

DASPHARMA0.40 ▪ 0.00
Last Trading Results
Opening Price
Day’s Low Price
Day’s High Price
Traded Volume171
Number of Deals
Gross Turnover66.69
Growth & Valuation
Earnings Per Share0.0853
Price/Earning Ratio4.69
Dividend Per Share0.00
Dividend Yield0%
Shares Outstanding84.8M
Market Capitalization33.9M
Monetary values are quoted in Ghana Cedi (GHS) unless otherwise stated

DASPHARMA Stock Market Performance


The current share price of Dannex Ayrton Starwin Plc (DASPHARMA) is GHS 0.40. DASPHARMA closed its last trading day (Friday, September 29, 2023) at 0.40 GHS per share on the Ghana Stock Exchange (GSE).

Dannex Ayrton Starwin is the 25th most traded stock on the Ghana Stock Exchange over the past three months (Jul 3 - Sep 29, 2023). DASPHARMA has traded a total volume of 2,641 shares valued at GHS 1,034 over the period, with an average of 42 traded shares per session. A volume high of 1,000 was achieved on September 14th for the same period. The table below details the last 10 trading days of activity of Dannex Ayrton Starwin on the Ghana Stock Exchange.


Profile of Dannex Ayrton Starwin Plc

Dannex Ayrton Starwin Plc operates in the Health Care sector, specifically, the Pharmaceuticals & Biotechnology industry.

Factsheet of Dannex Ayrton Starwin Plc

Health Care
Pharmaceuticals & Biotechnology
No. GA-172-1676, Shidaa Street, P. O. Box 5258, North Kaneshie, Accra, Ghana
+233-302-232-574, +233-302-232-575, +233-26-372-9394

DASPHARMA Industrial Market Competitors

Dannex Ayrton Starwin Plc, issuers of the DASPHARMA stock on the Ghana Stock Exchange, have one market competitor who is also engaged in the Health Care sector and/or Pharmaceuticals & Biotechnology industry. The table below presents an overview of their market standing.

CodeNameM. Cap.CloseYTD
IILIntravenous Infusions Limited10.4M0.04

Index of African Stock Exchanges:

  1. Botswana Stock Exchange
  2. BRVM Stock Exchange
  3. Ghana Stock Exchange
  4. Johannesburg Stock Exchange
  5. Lusaka Securities Exchange
  6. Malawi Stock Exchange
  7. Nairobi Securities Exchange
  8. Nigerian Stock Exchange
  9. Uganda Securities Exchange
  10. Zimbabwe Stock Exchange


  1. Isaac Francis AntwiIsaac Francis Antwi
    Jan 1, 2021 11:32 GMT

    Good morning, please, I have read that the DASPHARMA started operations in 2019. I would like to find out if I could get 2019 annual reports for my thesis work.
    Isaac Francis Antwi

  • Showing 1 - 1 of 1
NOTE: You are replying to 's comment. [Cancel]